Wikidata entity: Q412415
Cl₂H₆N₂Pt (P274)
Quantities
| P2067 | mass | 298.955595 |
| P233 | canonical SMILES | String | Cl[Pt]([NH3])([NH3])Cl | ??? |
| P373 | Commons category | String | Cisplatin | ??? |
| P527 | has part(s) | ... | Q880 (platinum) | platinum |
| P366 | has use | ... | Q12140 (medication) | medication |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Cisplatin-3D-balls.png | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2017 | isomeric SMILES | String | Cl[Pt@SP1]([NH3])([NH3])Cl | ??? |
| P3493 | legal status (medicine) | ... | Q879952 (boxed warning) | boxed warning |
| P2175 | medical condition treated | ... | Q122222 (subependymal giant cell astrocytoma) | subependymal giant cell astrocytoma |
| P2175 | medical condition treated | ... | Q128581 (breast cancer) | breast cancer |
| P2175 | medical condition treated | ... | Q172341 (ovarian cancer) | ovarian cancer |
| P2175 | medical condition treated | ... | Q181257 (prostate cancer) | prostate cancer |
| P2175 | medical condition treated | ... | Q189588 (stomach cancer) | stomach cancer |
| P2175 | medical condition treated | ... | Q324464 (testicular cancer) | testicular cancer |
| P2175 | medical condition treated | ... | Q372701 (esophageal cancer) | esophageal cancer |
| P2175 | medical condition treated | ... | Q504775 (bladder cancer) | bladder cancer |
| P2175 | medical condition treated | ... | Q549534 (osteosarcoma) | osteosarcoma |
| P2175 | medical condition treated | ... | Q852423 (laryngeal cancer) | laryngeal cancer |
| P2175 | medical condition treated | ... | Q938205 (neuroblastoma) | neuroblastoma |
| P2175 | medical condition treated | ... | Q467635 (multiple myeloma) | multiple myeloma |
| P2175 | medical condition treated | ... | Q1783924 (head and neck cancer) | head and neck cancer |
| P2175 | medical condition treated | ... | Q2501186 (transitional cell carcinoma) | transitional cell carcinoma |
| P2175 | medical condition treated | ... | Q3658562 (non-small-cell lung carcinoma) | non-small-cell lung carcinoma |
| P2175 | medical condition treated | ... | Q4742183 (amelanotic melanoma) | amelanotic melanoma |
| P2175 | medical condition treated | ... | Q1607658 (hepatoblastoma) | hepatoblastoma |
| P2175 | medical condition treated | ... | Q28757362 (tongue squamous cell carcinoma) | tongue squamous cell carcinoma |
| P2175 | medical condition treated | ... | Q55998694 (neuroblastoma, susceptibility to) | neuroblastoma, susceptibility to |
| P2175 | medical condition treated | ... | Q56014469 (bone sarcoma) | bone sarcoma |
| P2175 | medical condition treated | ... | Q12284921 (lymphosarcoma) | lymphosarcoma |
| P2175 | medical condition treated | ... | Q18348812 (head and neck squamous cell carcinoma) | head and neck squamous cell carcinoma |
| P2175 | medical condition treated | ... | Q18555254 (germ cell cancer) | germ cell cancer |
| P2175 | medical condition treated | ... | Q18556020 (lung benign neoplasm) | lung benign neoplasm |
| P2175 | medical condition treated | ... | Q18556047 (gastric adenocarcinoma) | gastric adenocarcinoma |
| P2175 | medical condition treated | ... | Q18556782 (lung oat cell carcinoma) | lung oat cell carcinoma |
| P2175 | medical condition treated | ... | Q18557991 (Hodgkin's lymphoma, mixed cellularity) | Hodgkin's lymphoma, mixed cellularity |
| P2175 | medical condition treated | ... | Q18975788 (spindle cell sarcoma) | spindle cell sarcoma |
| P361 | part of | ... | Q21095320 (cellular response to cisplatin) | cellular response to cisplatin |
| P361 | part of | ... | Q21114810 (response to cisplatin) | response to cisplatin |
| P3489 | pregnancy category | ... | Q28123618 (US pregnancy category D) | US pregnancy category D |
| P769 | significant drug interaction | ... | Q388801 (furosemide) | furosemide |
| P769 | significant drug interaction | ... | Q410400 (phenytoin) | phenytoin |
| P769 | significant drug interaction | ... | Q5473363 (fosphenytoin) | fosphenytoin |
| P769 | significant drug interaction | ... | Q1758380 (tobramycin) | tobramycin |
| P9989 | stylized name | String | CISplatin | ??? |
| P279 | subclass of | ... | Q1869679 (organoplatinum compounds) | organoplatinum compounds |
| P2868 | subject has role | ... | Q35456 (essential medicine) | essential medicine |
| P2868 | subject has role | ... | Q187661 (carcinogen) | carcinogen |
| P2868 | subject has role | ... | Q2126468 (radiosensitizer) | radiosensitizer |
| P2868 | subject has role | ... | Q2853144 (antineoplastic) | antineoplastic |
| P2868 | subject has role | ... | Q4118287 (DNA polymerase inhibitors) | DNA polymerase inhibitors |
| P2868 | subject has role | ... | Q50429956 (cross-linking reagent) | cross-linking reagent |
| P2868 | subject has role | ... | Q7202320 (platinum-based antineoplastic) | platinum-based antineoplastic |
| P267 | ATC code | L01XA01 |
| P5019 | Brockhaus Enzyklopädie online ID | cisplatin |
| P7524 | CA PROP 65 ID | cisplatin |
| P11931 | CAMEO Chemicals ID | 24020 |
| P231 | CAS Registry Number | 15663-27-1 |
| P683 | ChEBI ID | 27899 |
| P592 | ChEMBL ID | CHEMBL11359 |
| P661 | ChemSpider ID | 76401 |
| P715 | DrugBank ID | DB00515 |
| P8494 | DSSTOX compound identifier | DTXCID90227183 |
| P3117 | DSSTox substance ID | DTXSID50275807 |
| P232 | EC number | 239-733-8 |
| P2566 | ECHA Substance Infocard ID | 100.036.106 |
| P9635 | electronic Essential Medicines List medicine ID | 79 |
| P646 | Freebase ID | /m/04xnqp |
| P1578 | Gmelin number | 2519 |
| P12385 | Gran Enciclopèdia Catalana ID | cisplati |
| P1296 | Gran Enciclopèdia Catalana ID (former scheme) | 0090769 |
| P595 | Guide to Pharmacology Ligand ID | 5343 |
| P2062 | HSDB ID | 3939 |
| P2057 | Human Metabolome Database ID | HMDB0014656 |
| P4168 | IEDB Epitope ID | 194799 |
| P234 | InChI | InChI=1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2 |
| P235 | InChIKey | LXZZYRPGZAFOLE-UHFFFAOYSA-L |
| P665 | KEGG ID | D00275 |
| P10245 | MedlinePlus drug identifier | a684036 |
| P486 | MeSH descriptor ID | D002945 |
| P672 | MeSH tree code | D01.210.375 |
| P672 | MeSH tree code | D01.625.125 |
| P672 | MeSH tree code | D01.710.100 |
| P6366 | Microsoft Academic ID (discontinued) | 2778239845 |
| P2004 | NALT ID | 10462 |
| P8189 | National Library of Israel J9U ID | 987007286296705171 |
| P2115 | NDF-RT ID | N0000146476 |
| P3222 | NE.se ID | cisplatin |
| P691 | NL CR AUT ID | ph707356 |
| P2840 | NSC number | 119875 |
| P2840 | NSC number | 758184 |
| P10283 | OpenAlex ID | C2778239845 |
| P4235 | PatientsLikeMe treatment ID | cisplatin |
| P3636 | PDB ligand ID | CPT |
| P11199 | Probes And Drugs ID | PD001382 |
| P662 | PubChem CID | 5460033 |
| P3417 | Quora topic ID | Cisplatin |
| P657 | RTECS number | TP2450000 |
| P3345 | RxNorm CUI | 2555 |
| P2877 | SureChEMBL ID | 6043 |
| P2877 | SureChEMBL ID | 3789 |
| P2877 | SureChEMBL ID | 789130 |
| P2877 | SureChEMBL ID | 668194 |
| P695 | UN number | 3288 |
| P11089 | UniChem compound ID | 292460 |
| P652 | UNII | BW0OY6ZTD4 |
| P652 | UNII | Q20Q21Q62J |
| P11143 | WikiProjectMed ID | Cisplatin |
| P679 | ZVG number | 490577 |
Why not click here or view trends?
log id: 1554224